Wardell M R, Chang W S, Bruce D, Skinner R, Lesk A M, Carrell R W
Department of Haematology, University of Cambridge, MRC Centre, Hills Road, Cambridge CB2 2QH, United Kingdom.
Biochemistry. 1997 Oct 21;36(42):13133-42. doi: 10.1021/bi970664u.
The inhibitory mechanism of the serpin family of serine protease inhibitors is characterized by a remarkable degree of conformational flexibility. Various conformational states have been elucidated by X-ray crystallography and indicate that the inhibitory loop, the central A-beta-sheet, and the outside edge of the C-beta-sheet are particularly mobile. However, no crystal structure of a serpin-enzyme complex is yet available, and the likely nature of the protease-complexed serpin remains for biochemical and biophysical researchers to examine. Here, we show that the biochemical induction of the latent state of antithrombin is slow relative to polymer formation, and infer that this may reflect structural features that are important for the regulation of the initial docking and subsequent locking of serpins with cognate proteases. L-Antithrombin was induced by incubation of native antithrombin at 60 degrees C for 10 h in the presence of citrate to prevent polymerization. L-Antithrombin was more stable to denaturation by both heat and urea than native antithrombin. Whereas native antithrombin formed binary complexes with synthetic peptide homologues of the inhibitory loop, biochemically induced L-antithrombin did not, indicating that the inhibitory loop of L-antithrombin is probably fully inserted into the A-beta-sheet as in the crystal structure. This was confirmed by limited proteolysis studies which demonstrated that the inhibitory loop of L-antithrombin could not be cleaved by five proteases which do cleave the loop of native antithrombin. The limited proteolysis studies also indicated that the "gate" region (residues 236-248) of the biochemically induced L-antithrombin was in a conformation substantially different from that of the native antithrombin. This again is similar to L-antithrombin in the crystal structure in which the gate has "opened" away from the body of the molecule by a rotation of 24 degrees to facilitate the relocation of strand 1C from its ordered position in the C-beta-sheet to a disordered surface loop. At 60 degrees C in the absence of citrate, antithrombin (and other serpins) rapidly polymerizes. In the presence of citrate, the formation of L-antithrombin is slow and increases with time, indicating that the inhibition of polymer formation by citrate allows the time necessary for the much slower formation of the L form. We therefore suggest that L-antithrombin formation is a two-step process: an initial rapid conformational change, probably including partial incorporation of the reactive loop into the A-sheet (as in the active molecule in the crystal structure) and displacement of s1C from the C-beta-sheet which supports polymer formation, and a much slower transition to complete loop insertion within the A-beta-sheet. It is likely that both the first rapid transitional step and the structural features that impose resistance to the second more extensive conformational change reflect the optimization of the unique inhibitory function in the serpins.
丝氨酸蛋白酶抑制剂丝氨酸蛋白酶抑制剂家族的抑制机制具有显著程度的构象灵活性。通过X射线晶体学已经阐明了各种构象状态,表明抑制环、中央A-β-折叠片和C-β-折叠片的外边缘特别具有流动性。然而,目前尚无丝氨酸蛋白酶抑制剂-酶复合物的晶体结构,蛋白酶复合丝氨酸蛋白酶抑制剂的可能性质仍有待生物化学和生物物理研究人员去研究。在这里,我们表明抗凝血酶潜伏状态的生化诱导相对于聚合物形成较慢,并推断这可能反映了对丝氨酸蛋白酶抑制剂与同源蛋白酶的初始对接和随后锁定起调节作用的重要结构特征。在柠檬酸盐存在下,将天然抗凝血酶在60℃孵育10小时诱导生成L-抗凝血酶,以防止聚合。L-抗凝血酶比天然抗凝血酶对热和尿素变性更稳定。虽然天然抗凝血酶与抑制环的合成肽类似物形成二元复合物,但生化诱导的L-抗凝血酶则不然,这表明L-抗凝血酶的抑制环可能如晶体结构中那样完全插入到A-β-折叠片中。有限的蛋白水解研究证实了这一点,该研究表明L-抗凝血酶的抑制环不能被五种能切割天然抗凝血酶环的蛋白酶切割。有限的蛋白水解研究还表明,生化诱导的L-抗凝血酶的“门”区域(第236-248位残基)的构象与天然抗凝血酶的构象有很大不同。这再次与晶体结构中的L-抗凝血酶相似,其中门通过24度的旋转从分子主体“打开”,以促进1C链从其在C-β-折叠片中的有序位置重新定位到无序的表面环。在60℃且无柠檬酸盐的情况下,抗凝血酶(和其他丝氨酸蛋白酶抑制剂)会迅速聚合。在柠檬酸盐存在下,L-抗凝血酶的形成缓慢且随时间增加,表明柠檬酸盐对聚合物形成的抑制作用使得形成L型所需的慢得多的时间成为可能。因此,我们认为L-抗凝血酶的形成是一个两步过程:最初的快速构象变化,可能包括反应环部分插入A-折叠片(如晶体结构中的活性分子)以及支持聚合物形成的s1C从C-β-折叠片中位移,以及向抑制环完全插入A-β-折叠片的慢得多的转变。很可能第一个快速转变步骤以及对第二个更广泛构象变化产生抗性的结构特征都反映了丝氨酸蛋白酶抑制剂独特抑制功能的优化。